Virtual Medicinal Product (VMP)
-
Agalsidase beta 5mg powder for solution for infusion vials
Name Details
Current Name
Agalsidase beta 5mg powder for solution for infusion vials
|
Start Date
13-01-2009
|
End Date
|
Previous Name
Agalsidase beta 5mg powder for solution for injection vials
|
Start Date
05-09-2005
|
End Date
12-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A16AB04
BNF |
Current BNF
09080100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
09080100
|
Start Date
05-09-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41758111000001109 |
09-05-2023 |
|
413468006 |
08-09-2005 |
08-05-2023 |
VMP Ingredients
Name
Agalsidase beta
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5
Strength and UOM (Dmr)
Virtual Medicinal Product Pack (VMPP) Information